Tilus, Riezza Ann H.
HRN: 26-85-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
CO-AMOXICLAV 625MG (TAB)
02/03/2026
02/10/2026
PO
625 MG/TAB
TID
CAP LR
Checking Initial Appropriateness
02/03/2026
AZITHROMYCIN 500MG TABLET (TAB)
02/03/2026
02/07/2026
PO
500mg
OD
CAP LR
Checking Initial Appropriateness
02/04/2026
CEFTRIAXONE 1G (VIAL)
02/04/2026
02/10/2026
IV
2g
OD
UTI
Checking Initial Appropriateness